SequelSEC

Sight Sciences, Inc. SGHT

Surgical & Medical Instruments & Apparatus · CIK 0001531177 · Fiscal year ends 1231

Revenue
$83.38M
Fiscal year ended 2026-06-30
Operating income
-$27.88M
Fiscal year ended 2026-06-30
Free cash flow
-$23.33M
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$153.60MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$2.84Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue2.0×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity2.4×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Surgical & Medical Instruments & Apparatus filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
CapEx / revenue0.3%4th
Gross margin86.2%96th
Current ratio10.22x92th
Revenue YoY growth-3.1%18th
SBC / revenue16.9%72th
FCF margin-38.7%35th
Operating margin-48.0%37th
Net margin-49.7%38th
Long-term debt / equity0.63x57th
R&D / revenue18.9%57th

Sight Sciences, Inc. (SGHT) reported revenue of $83.38M and net income of -$29.76M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Sight Sciences, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

Sight Sciences, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$83.38M
Cost of revenue$10.04M
Gross profit$73.34M
Operating income-$27.88M
Net income-$29.76M
Research & development$10.85M
Weighted-average diluted sharesUnavailable
Pretax income-$29.79M
Income tax expense-$32.00K
Diluted EPSUnavailable
Selling, general & administrative$90.36M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

Sight Sciences, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$79.75M
Total assets$104.87M
Current assets$101.44M
Total liabilities$51.98M
Current liabilities$20.50M
Total equity incl. NCI$52.89M
Temporary (mezzanine) equityUnavailable
Inventory$5.70M
Accounts receivable$11.39M
GoodwillUnavailable
Long-term debt$30.64M
Accounts payable$1.90M

Cash flow

Sight Sciences, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$23.24M
Capital expenditures$93.00K
Investing cash flow-$93.00K
Financing cash flow$1.85M
Net change in cash-$21.48M
Stock-based compensation$10.78M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$410.00K

Derived

Sight Sciences, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow-$23.33M
Gross margin88.0%
Operating margin-33.4%
FCF margin-28.0%
SBC / revenue12.9%
Current ratio4.95x
Revenue YoY growth9.3%
Net margin-35.7%
R&D / revenue13.0%
CapEx / revenue0.1%
Long-term debt / equity0.58x
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open SGHT in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-05View SEC filing
10-Q · Filed 2026-05-06View SEC filing
10-K · Filed 2026-03-04View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-08View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.